Landec Corp. (LNDC) Trading Down 2.1%
Landec Corp. (NASDAQ:LNDC) traded down 2.1% during trading on Thursday . The stock traded as low as $10.55 and last traded at $10.63, with a volume of 88,324 shares trading hands. The stock had previously closed at $10.86.
Several research firms have recently issued reports on LNDC. Zacks Investment Research upgraded Landec Corp. from a “sell” rating to a “hold” rating in a research report on Tuesday, June 7th. Maxim Group began coverage on Landec Corp. in a research report on Tuesday, June 7th. They issued a “buy” rating and a $16.00 price target on the stock. Finally, Wedbush began coverage on Landec Corp. in a research report on Thursday, July 7th. They issued a “neutral” rating and a $12.00 price target on the stock. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Landec Corp. presently has an average rating of “Buy” and an average price target of $15.10.
The firm’s market cap is $308.36 million. The firm has a 50-day moving average of $11.01 and a 200-day moving average of $11.02.
An institutional investor recently raised its position in Landec Corp. stock. Heartland Advisors Inc. raised its stake in Landec Corp. (NASDAQ:LNDC) by 5.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 936,452 shares of the company’s stock after buying an additional 52,509 shares during the period. Heartland Advisors Inc. owned approximately 3.46% of Landec Corp. worth $11,078,000 as of its most recent SEC filing.
Landec Corporation designs, develops, manufactures and sells differentiated products for food and biomaterials markets and licenses technology applications to partners. The Company’s segments include Food Products Technology, Food Export and Hyaluronan-based Biomaterials. The Company’s Food Products Technology segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.